Randomized Controlled Trial August 6, 2026

Omega-3s May Ease Methamphetamine-Related Lung Damage in Rat Study

Detoxification Immune System Membranes Metabolism

This study looked at how methamphetamine affects lung tissue in rats, and whether omega-3 fatty acids (EPA/DHA) could reduce the damage. Twenty male rats were split into four groups and given either methamphetamine, omega-3s, both, or neither once daily for 60 days.

Methamphetamine alone caused a range of harmful changes in lung tissue, including increased oxidative stress markers, depleted antioxidants, signs of inflammation and immune cell infiltration, markers of cell death (apoptosis), and disrupted energy metabolism. Tissue examination showed inflammation and fluid buildup around blood vessels in the lungs of methamphetamine-only rats.

Rats given omega-3s alongside methamphetamine showed measurable improvement in several of these markers, including inflammatory enzyme activity, DNA fragmentation, an energy-metabolism enzyme, lactate buildup, and one antioxidant. Other markers showed improvement trends that weren’t statistically significant. The researchers describe this as partial protection against the metabolic and inflammatory disruption caused by methamphetamine in this animal model.

What this means for you

This is an early-stage animal study, not a human trial, and it does not suggest omega-3 supplements treat or prevent drug-related lung damage. It offers a starting point for future research into how omega-3 fatty acids interact with oxidative stress and inflammation in lung tissue, but no conclusions can be drawn for people at this stage.

Ready to start? The ALP Protocol delivers the EPA & DHA doses used in the research.

Start the ALP Protocol

Source

Biochemical and biophysical research communications · 2026-08-06 · DOI: 10.1016/j.bbrc.2026.154405

Read the original source ↗

This summary is for educational purposes only and is not medical advice. Always talk to your healthcare provider before making changes to your supplement routine.